½ÃÀ庸°í¼­
»óǰÄÚµå
1415530

¹Ì±¹ÀÇ »ý¸í°úÇÐ ¿¬±¸ Åø ¼ºÀå ±âȸ

US Life Sciences Research Tools Growth Opportunities

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Frost & Sullivan | ÆäÀÌÁö Á¤º¸: ¿µ¹® 41 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Cancer Moonshot°ú ARPA: HÀÇ Çõ½ÅÀûÀÎ ÀÚ±Ý Áö¿øÀ¸·Î »ý¹°ÀÇÇÐ ¹× °Ç°­ ¿¬±¸ °­È­

Frost & SullivanÀÇ 2024³â±îÁöÀÇ ¼¼°è IoT »ê¾÷ Àü¸ÁÀº Frost & SullivanÀÇ °¢ Áö¿ª IoT ¹× ¿§Áö ¿¬±¸ÆÀÀÇ Á¤º¸¸¦ Á¾ÇÕÇÑ °á°úÀÔ´Ï´Ù. ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®µéÀÇ ÀǰßÀº Frost &SullivanÀÇ ±¤¹üÀ§ÇÑ Áö½Ä ±â¹Ý°ú 1Â÷ ¹× 2Â÷ Á¶»ç¸¦ Ȱ¿ëÇß½À´Ï´Ù.

À̹ø '¼ºÀå ±âȸ Åé 10 º¸°í¼­´Â 2024³â ÁÖ¸ñÇØ¾ß ÇÒ ÁÖÁ¦¸¦ ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä Æ®·»µå´Â IoT ±â¼úÀÇ ÃֽŠÇõ½Å, »õ·Î¿î ºñÁî´Ï½º ¸ðµ¨, »õ·Î¿î ÀÌ¿ë »ç·Ê, º¸´Ù ¾ÈÀüÇϰí ź¼Ò Á߸³ÀûÀÎ Á¢±Ù ¹æ½ÄÀ» ±â¹ÝÀ¸·Î ÇÑ ±â¾÷ÀÇ µðÁöÅÐ Çõ½Å ¿©Á¤À» À§ÇÑ Ãֽгë·Â¿¡ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀÔ´Ï´Ù.

À̹ø Á¶»ç´Â 2023³â 4ºÐ±â¿¡ 688¸íÀÇ IT ÀÇ»ç°áÁ¤ÀÚ(ITDM)¸¦ ´ë»óÀ¸·Î ºÏ¹Ì, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ´Ù¾çÇÑ ±Ô¸ð¿Í ¾÷Á¾ÀÇ Á¶Á÷À» ´ë»óÀ¸·Î IoT º¸¾È ¹× µµÀÔ¿¡ ´ëÇÑ Áú¹®À¸·Î ±¸¼ºµÈ ÃֽŠIT ÀÇ»ç°áÁ¤ÀÚ(ITDM) ¼³¹®Á¶»ç¸¦ ½Ç½ÃÇÏ¿´½À´Ï´Ù. ¶ÇÇÑ, À̹ø Á¶»ç¿¡¼­´Â ´Ù¾çÇÑ ¼ºÀå ±âȸ¿¡ µû¶ó 2024³âºÎÅÍ 2026³â±îÁöÀÇ ¸ÅÃâ°ú ´©Àû IoT ±â±â ¼ö¸¦ ¿¹ÃøÇß½À´Ï´Ù.

¸¶Áö¸·À¸·Î, Frost &SullivanÀÇ ÀÌ º¸°í¼­´Â ³íÀÇµÈ ´Ù¾çÇÑ ÁÖÁ¦¿¡ ´ëÇØ ´õ ±íÀÌ ÆÄ°íµé ¼ö ÀÖ´Â ±ÇÀå »çÇ×°ú Âü°í ÀڷḦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Àü·«Àû Çʼö ¿ä°Ç

  • ¿Ö ¼ºÀåÀÌ ¾î·Á¿öÁö°í Àִ°¡?
  • The Strategic Imperative 8(TM)
  • »ý¸í°úÇÐ ¿¬±¸ Åø ¾÷°è Àü·«Àû Çʼö ¿ä°ÇÀÇ ¿µÇâ
  • ¼ºÀå ±âȸ°¡ Growth Pipeline Engine(TM)À» °¡¼Ó

¼ºÀå ±âȸ ºÐ¼®

  • ºÐ¼® ¹üÀ§
  • ¼¼ºÐÈ­
  • »ý¸í°úÇÐ ¿¬±¸ : COVID-19 ÆÒµ¥¹Í ÀÌÈÄ ÃѰý
  • ÀÌÇØ°ü°èÀÚ ÀÚ±ÝÁ¶´Þ »óȲ : NIH ÁÖ¿ä ÀÚ±Ý Á¦°ø ±â°ü
  • ÀÌÇØ°ü°èÀÚ ÀÚ±ÝÁ¶´Þ »óȲ : NIH Á¶Á÷ ¿¹»ê
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ¼ºÀå ȯ°æ : NIH ¿¹»ê Áõ°¡ : ¼Ò°ß
  • ¼ºÀå ȯ°æ : ¹Î°£ °Å·¡¿Í OI ½ºÆ÷Æ®¶óÀÌÆ®
  • ¼ºÀå ȯ°æ : ¿¹»ê Áõ°¡
  • ¼ºÀå ȯ°æ : 2023³â ½ÇÇè½Ç Á¦Ç° ¿¹»ê ³»¿ª°ú 2024³â µ¿Çâ
  • ¼ºÀå ȯ°æ : °ø±Þ¸Á °úÁ¦°¡ ¿¬±¸¼Ò¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • Æ®·»µå 1 - NIH ¿¹»ê°ú ¿¬±¸ µµ±¸ »ê¾÷¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • Æ®·»µå 2 - 25¾ï ´Þ·¯·Î °íÀ§Çè, °íº¸»ó ¿¬±¸¸¦ ÃßÁøÇÏ´Â ARPA-H
  • Æ®·»µå 3-¾Ï ¿¬±¸¿¡ ´Ù½Ã ºÒÀ» ºÙÀÌ´Â 2024 ȸ°è¿¬µµ ¿¬¹æ ¿¹»ê¾È

¼ºÀå ±âȸ

  • ¼ºÀå ±âȸ 1 : ¾Ï ¿¬±¸
  • ¼ºÀå ±âȸ 2 : ÇÁ·ÎÅ׿À¹Í½º
  • ¼ºÀå ±âȸ 3 : °³¹æÇü Çõ½Å
  • ¼ºÀå ±âȸ 4 : À¯¼¼Æ÷ºÐ¼®±â
  • µµÇ¥
  • ¸éÃ¥»çÇ×
LSH 24.02.01

Innovative Financing in Cancer Moonshot and ARPA-H Strengthens Biomedical and Health Research

Frost & Sullivan's global IoT industry predictions for calendar 2024 are the result of aggregated input from Frost & Sullivan regional IoT and Edge research teams. Research analysts' input leverages the extensive Frost & Sullivan knowledge base, as well as primary and secondary research.

This Top 10 Growth Opportunities report reflects the hot topics for 2024. Major trends will impact the latest innovations of IoT technologies, new business models, emerging use cases, and the latest initiatives for companies' digital transformation journey under a more secure and carbon-neutral approach.

The study includes the findings of our latest IT Decision Makers' (ITDM) Survey, conducted in Q4 2023 with the participation of 688 ITDMs, comprising questions about IoT security and adoption, directed to organizations of various sizes and industries in North America, Europe, Asia-Pacific, and Latin America. Furthermore, the study forecasts revenue and cumulative IoT devices, from 2024 until 2026, in different growth opportunities.

Finally, this Frost & Sullivan report provides recommendations and reference studies for a deep dive into the different topics discussed.

Table of Contents

Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Life Sciences Research Tools Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

  • Scope of Analysis
  • Segmentation
  • Life Sciences Research-Post COVID-19 Pandemic Round-up
  • Stakeholder Funding Landscape-Key NIH-funded Institutions
  • Stakeholder Funding Landscape-NIH Organizational Budgets
  • Growth Drivers
  • Growth Restraints
  • Growth Environment-The NIH Budget Increases-Findings
  • Growth Environment-Spotlight on Private Sector Deals and OI
  • Growth Environment-Budget Increases
  • Growth Environment-2023 Laboratory Product Budget Breakdown and 2024 Trend
  • Growth Environment-Impact of Supply Chain Challenges on Laboratories
  • Trend 1-The NIH Budget and Its Impact on the Research Tools Industry
  • Trend 2-With $2.5 Billion, ARPA-H Drives High-risk, High-reward Research
  • Trend 3-Federal FY 2024 Budget Proposal Reignites Cancer Research

Growth Opportunity Universe

  • Growth Opportunity 1: Cancer Research
  • Growth Opportunity 2: Proteomics
  • Growth Opportunity 3: Open Innovation
  • Growth Opportunity 4: Flow Cytometry
  • List of Exhibits
  • Legal Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦